UBS Group’s Cyclo Therapeutics, Inc. Common Stock CYTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-11,987
| Closed | -$7.07K | – | 9448 |
|
|
2024
Q4 | $7.07K | Sell |
11,987
-471
| -4% | -$278 | ﹤0.01% | 7263 |
|
|
2024
Q3 | $9.83K | Buy |
12,458
+405
| +3% | +$320 | ﹤0.01% | 6555 |
|
|
2024
Q2 | $15.3K | Buy |
12,053
+7,225
| +150% | +$9.18K | ﹤0.01% | 6323 |
|
|
2024
Q1 | $6.71K | Buy |
+4,828
| New | +$6.71K | ﹤0.01% | 6273 |
|
|
2023
Q4 | – | Sell |
-88
| Closed | -$125 | – | 8700 |
|
|
2023
Q3 | $125 | Buy |
+88
| New | +$125 | ﹤0.01% | 7684 |
|
|
2023
Q2 | – | Sell |
-1,640
| Closed | -$1.38K | – | 8564 |
|
|
2023
Q1 | $1.38K | Sell |
1,640
-1,170
| -42% | -$983 | ﹤0.01% | 7652 |
|
|
2022
Q4 | $3.99K | Buy |
+2,810
| New | +$3.99K | ﹤0.01% | 8209 |
|
|
2022
Q3 | – | Sell |
-793
| Closed | -$2K | – | 9818 |
|
|
2022
Q2 | $2K | Sell |
793
-1,498
| -65% | -$3.78K | ﹤0.01% | 8596 |
|
|
2022
Q1 | $7K | Sell |
2,291
-10,620
| -82% | -$32.4K | ﹤0.01% | 7803 |
|
|
2021
Q4 | $48K | Sell |
12,911
-27,003
| -68% | -$100K | ﹤0.01% | 5850 |
|
|
2021
Q3 | $269K | Buy |
39,914
+28,820
| +260% | +$194K | ﹤0.01% | 4083 |
|
|
2021
Q2 | $113K | Buy |
11,094
+10,396
| +1,489% | +$106K | ﹤0.01% | 4752 |
|
|
2021
Q1 | $6K | Buy |
+698
| New | +$6K | ﹤0.01% | 7220 |
|